Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
05/2003
05/15/2003WO2003040098A1 Novel metalloproteinase inhibitors
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003WO2003040089A1 Thiols and disulphides and their use in producing substrates
05/15/2003WO2003040086A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof
05/15/2003WO2003039454A2 Beta-secretase inhibitors and methods of use
05/15/2003WO2002102983A3 Oligomers and polymers of di-substituted cyclic imino carboxylic acids
05/15/2003US20030092769 Diaryl-enynes
05/15/2003US20030092764 Oxidation resistance
05/15/2003US20030092746 Substituted amidine derivatives as inhibitors of cell adhesion
05/15/2003US20030092744 Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
05/15/2003US20030092715 Aryl and biaryl compounds having MCH modulatory activity
05/15/2003US20030092708 Anticholesterol agents; cardiovascular disorders; antilipemic agents
05/15/2003US20030092702 Antiinflammatory agents; autoimmune disease; autoimmune diseases
05/15/2003US20030092698 N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor Xa
05/15/2003US20030089592 Process for fractionating water-containing crude amine mixtures from amine synthesis
05/15/2003US20030089591 For the preparation of dimethylpropylamine from dimethylamine and propionaldehyde in the presence of hydrogen
05/15/2003CA2466391A1 Polyamide modulators of cox2 transcription
05/15/2003CA2466328A1 Isotopically coded affinity markers 3
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003CA2464763A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof
05/15/2003CA2464736A1 Beta-secretase inhibitors and methods of use
05/14/2003EP1310485A1 Pyrrole derivatives
05/14/2003EP1310482A1 Prodrugs of excitatory amino acids
05/14/2003EP1309575A1 Biphenyl derivatives and their use as ppar-gamma receptor activators
05/14/2003EP1309544A1 Compounds acting as melanocortin receptor ligands
05/14/2003EP1278743A4 Novel anti-infectives
05/14/2003EP0934313B1 N-substituted azaheterocyclic compounds
05/14/2003CN1418210A Carbocyclik side chain containing, N-substituted Metalloprotease inhibitors
05/14/2003CN1418209A Carbocyclic side chain containing metalloprotease inhibitors
05/14/2003CN1418191A Novel thiourea derivatives and the pharmaceutical compositions containing thd same
05/13/2003US6562825 For treating inflammatory disease including asthma and allergic diseases, as well as autoimmune pathologies
05/13/2003US6562806 Pyrrolobenzodiazepines
05/13/2003US6562613 Recombinant C-proteinase and processes, methods and uses thereof
05/13/2003CA2115443C Azabicyclo arylacetylene and arylenyne oximes as cholinergic agents and methods of treatment
05/08/2003WO2003038123A2 Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene
05/08/2003WO2003037872A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties
05/08/2003WO2003037871A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties
05/08/2003WO2003037853A1 Substituted thioacetamides
05/08/2003WO2003037338A2 Modulators of the cholesterol biosynthetic pathway
05/08/2003WO2003037327A1 N-substituted pyrrolidin derivatives as dipeptidyl peptidase iv inhibitors
05/08/2003WO2003037326A1 Solid phase synthesis of chemical libraries
05/08/2003WO2003037271A2 Compounds, pharmaceutical compositions and methods of use therefor
05/08/2003WO2003002595A3 Dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents
05/08/2003WO2002026750A8 Phosphino-aminophosphines, catalyst complexes and enantioselective hydrogenation
05/08/2003US20030087999 Thermosetting resin compositions containing maleimide and/or vinyl compounds
05/08/2003US20030087952 17-Beta-hydroxysteroid dehydrogenase-II inhibitors
05/08/2003US20030087950 New alpha-amino acid sulphonyl compounds
05/08/2003US20030087945 Sulfonylaminocarboxylic acids
05/08/2003US20030087939 Novel succinate derivative compounds useful as cysteine protease inhibitors
05/08/2003US20030087905 Containing a haloalkyl group: e.g., 3-((3-(3-trifluoromethoxyphenoxy) phenyl)((3-(1,1,2,2-tetrafluoroethoxy)phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol
05/08/2003US20030087890 Substituted carbocyclic or heterocyclic hydroxamic acid derivatives, e.g., (3R,4S)-N-hydroxy-1-methyl-3-(((4-((2-methyl-4 -quinolinyl)methoxylphenyl)sulfonyl)methyl)-4-piperidinecarboxamide
05/08/2003US20030087306 Methods for identifying novel multimeric agents that modulate receptors
05/08/2003CA2465350A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties
05/08/2003CA2465344A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties
05/08/2003CA2464995A1 Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene
05/08/2003CA2462206A1 Substituted thioacetamides
05/07/2003EP1308481A2 Metal-mediated cross-coupling with ring-metalated porphyrins
05/07/2003EP1308439A1 Proline derivatives and use thereof as drugs
05/07/2003EP1307470A2 Linked, sequence-specific dna-binding molecules
05/07/2003EP1029297B1 Method of virtual retrieval of analogs of lead compounds
05/07/2003EP1019358B1 3,3-diarylpropylamines , their use and preparation
05/07/2003EP0987267B1 Carbapenem compounds, use thereof, and intermediate compounds of the same
05/07/2003EP0912510B1 Nickel catalyzed addition of -nh- containing compounds to vinyl and aryl halides
05/07/2003EP0889863B1 Surface modified carbonate materials
05/07/2003EP0858464B1 Thrombin inhibitors
05/07/2003CN1416416A Androgen receptor suppressors in treatment of hirsutism,acne and androgenetic alopecia
05/07/2003CN1107766C Sizing of paper
05/06/2003US6559320 One pot process; reacting aldehyde and trialkylphohonoacetate in presence of alkali metal alkoxide; treating with toluenesulfonylmethyl isocyanide
05/06/2003US6559319 Synthesis of compounds useful in the manufacture of ketorolac
05/06/2003US6559140 Cyclic and bicyclic diamino histamine-3 receptor antagonists
05/06/2003US6559100 2-benzoyl-cyclohexane-1,3-diones
05/06/2003US6559091 Metal complex ligated by a monodentate, bidentate, tridentate, or tetradentate ligand, wherein at least one of the donor atoms of the ligand is a nitrogen atom substituted by a 1-pyrrolyl or substituted 1- pyrrolyl group
05/06/2003CA2032864C Peptide compounds, a process for preparation thereof and pharmaceutical composition comprising the same
05/02/2003EP1306371A1 Cyclic imines
05/02/2003EP1305304A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor
05/02/2003EP1305292A1 Biphenyl carboxamides
05/02/2003EP1305284A1 Process and intermediate compounds for the preparation of pyrrolidines
05/02/2003EP1304994A1 Pyrrolyl-substituted nitrophenols used as direct colorants
05/02/2003EP1056704B1 Antitumor agents
05/02/2003EP1045846B1 Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof
05/02/2003EP1019371B1 Dimaleinimido-substituted dihydroxyalkanes which can be used as crosslinking reagents and process for their preparation
05/02/2003EP1015428B1 Sulfo-n-hydroxy succinimide and method of preparation
05/02/2003EP0831799B1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders
05/01/2003WO2003035647A1 Alkyl ether derivatives or salts thereof
05/01/2003WO2003035627A1 Piperazine derivatives with ccr1 receptor antagonist activity
05/01/2003WO2003035619A1 Tyrosine kinase inhibitors
05/01/2003WO2003035616A2 Tyrosine kinase inhibitors
05/01/2003WO2003035615A2 Tyrosine kinase inhibitors
05/01/2003WO2003035614A2 Tyrosine kinase inhibitors
05/01/2003WO2003035602A1 Lipid modulators
05/01/2003WO2003035059A2 Spermicides
05/01/2003WO2003035058A2 Polymaleide compounds and their medical use
05/01/2003WO2003035057A1 Inhibitors of dipeptidyl peptidase iv
05/01/2003WO2003035055A1 Mch antagonists for the treatment of obesity
05/01/2003WO2003034900A2 Sterile, breathable patch for treating wound pain
05/01/2003WO2003005824A3 Substituted 3-heteroaryl (amino-or-oxy)-pyrrolidin-2-ones, method for the production thereof and use thereof as herbicides or as plant growth regulators
05/01/2003WO2002046158A9 Piperidine/piperazine-type inhibitors of p38 kinase
05/01/2003WO2002044113A9 Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
05/01/2003WO2002024642A8 Method for producing δ1-pyrrolines
05/01/2003US20030083504 N- (4-carbamimidoyl-phenyl) -glycine derivatives
1 ... 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 ... 404